Amrutanjan Health Care Share Price Today | Stock Price & Amrutanjan Health Care Share Screener
As of October 5, 2026, the live Amrutanjan Health Care share price (NSE: AMRUTANJAN) is ₹518.10 on NSE and ₹517.00 on BSE, up 0.95% from the previous close, with shares trading between ₹511.00 and ₹524.00 in today's trading session, and a 52-week range of ₹488.25–₹741.50. Check AMRUTANJAN 52-week chart for the annual price range and momentum. Use the Amrutanjan Health Care stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Amrutanjan Health Care opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Amrutanjan Health Care Share Price Chart
Track the current stock price of Amrutanjan Health Care with an interactive chart. Analyse AMRUTANJAN share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Amrutanjan Health Care stock quote in one place.
The quote of ₹518.10 sits between the 52-week low of ₹488.25 and the 52-week high of ₹741.50, and the latest session moved 0.95% from the previous close.
Amrutanjan Health Care Company Profile - Fundamental Screener
Screen Amrutanjan Health Care company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for AMRUTANJAN shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE098F01031.
Company Details
Classification
Identifiers and Leadership
Amrutanjan Health Care Balance Sheet Screener
Screen AMRUTANJAN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2016, total assets were ₹140, up from ₹124 in 2015.
Latest statistics put total assets at ₹140 and shareholder funds at ₹109, with a leverage ratio of 0.02.
| Item | 2016 | 2015 |
|---|---|---|
Assets |
||
| Total Assets | 140 | 124 |
| Current Assets | 101 | 83 |
| Fixed Assets | 29 | 24 |
Liabilities |
||
| Total Liabilities | 0 | 0 |
| Current Liabilities | 4 | 3 |
| Non-Current Liabilities | 0 | 0 |
Shareholders' Equity |
||
| Total Equity | 109 | 95 |
| Share Capital | 3 | 3 |
| Reserves & Surplus | 106 | 92 |
Amrutanjan Health Care Income Statement Screener - Profit & Revenue Analysis
Screen Amrutanjan Health Care income statement and profit fundamentals. Analyze AMRUTANJAN quarterly results. Amrutanjan Health Care reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹0 and net profit was ₹0.
In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2016-March, shows revenue of ₹192 and net profit of ₹21.
| Item | None-None | 2016-March | 2015-March |
|---|---|---|---|
Revenue and Expenses | |||
| Revenue | 0 | 192 | 171 |
| Expenses | 0 | 156 | 143 |
Operating Costs and Margins | |||
| EBITDA | 0 | 37 | 28 |
| Operating Profit % | 0.00% | 16.00% | 14.00% |
| Depreciation | 0 | 3 | 3 |
| Interest | 0 | 0 | 1 |
Profit and Earnings | |||
| Profit Before Tax | 0 | 32 | 24 |
| Tax | 0 | 12 | 9 |
| Net Profit | 0 | 21 | 15 |
| EPS | 0.00 | 14.08 | 10.31 |
Amrutanjan Health Care Cash Flow Screener - Liquidity Fundamentals
Screen AMRUTANJAN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2016-March, operating activities generated ₹21, and net cash flow was an inflow of ₹12.
Over the same period, investing activities provided ₹4 and financing activities used ₹13.
| Item | 2016-March | 2015-March |
|---|---|---|
Cash from Operations and Investing | ||
| Operating Activities | 21 | 18 |
| Investing Activities | 4 | -5 |
Financing and Net Cash | ||
| Financing Activities | -13 | -12 |
| Net Cash Flow | 12 | 2 |
Amrutanjan Health Care Shareholding Pattern Screener
See Amrutanjan Health Care shareholding pattern with promoter, FII, and DII holdings. Check Amrutanjan Health Care promoter holding and ownership changes for AMRUTANJAN on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 46.52%, foreign institutions 2.17%, domestic institutions 12.66% and the public 32.20%, spread across 45,805 shareholders.
The shareholder count was 45,805 in 2026-Mar, compared with 45,135 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 46.52% | 46.52% | 46.52% | 46.52% | 46.52% | 46.52% | 50.59% | 50.59% |
Institutional Investors | ||||||||
| FII Holding | 2.17% | 2.44% | 2.30% | 2.41% | 2.38% | 2.27% | 1.38% | 1.55% |
| DII Holding | 12.66% | 12.28% | 11.41% | 12.70% | 12.90% | 13.00% | 7.29% | 7.32% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 32.20% | 32.06% | 33.56% | 32.28% | 32.18% | 32.09% | 34.17% | 33.87% |
| Other Holding | 6.45% | 6.70% | 6.22% | 6.09% | 6.02% | 6.13% | 6.57% | 6.67% |
| Shareholder Count | 45,805 | 45,135 | 51,674 | 49,431 | 47,954 | 46,675 | 62,664 | 57,169 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Amrutanjan Health Care. Amrutanjan Health Care dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹4.90 per unit for 2026-March, a yield of 0.97%, compared with ₹4.60 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹4.90, ₹4.60 and ₹4.60 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹4.90 | 0.97% |
| 2025-March | ₹4.60 | 0.93% |
| 2024-March | ₹4.60 | 0.71% |
| 2023-March | ₹4.60 | 0.74% |
| 2022-March | ₹4.60 | 0.80% |
| 2021-March | ₹4.20 | 0.53% |
| 2020-March | ₹2.10 | 0.37% |
| 2019-March | ₹2.15 | 0.65% |
| 2018-March | ₹3.05 | 0.99% |
| 2017-March | ₹3.85 | 1.42% |
Amrutanjan Health Care Stock Index Membership - Nifty & Sensex
See which indices include Amrutanjan Health Care stock. Check AMRUTANJAN index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Amrutanjan Health Care Market Events Screener - Corporate Actions
Get Amrutanjan Health Care corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Amrutanjan Health Care stock events that may affect AMRUTANJAN share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 23, 2026, with a record date of September 23, 2026.
It is followed by Dividend dated September 11, 2026 and Quarterly Result Announcement dated August 11, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-23 | 2026-09-23 | Annual General Meeting | NA | -5.63% |
| 2026-09-11 | 2026-09-11 | Dividend | ₹ 2.90 /share | -11.61% |
| 2026-08-11 | 2026-08-11 | Quarterly Result Announcement | NA | 2.46% |
| 2026-05-08 | 2026-05-08 | Quarterly Result Announcement | NA | -3.93% |
| 2026-02-06 | 2026-02-07 | Dividend | ₹ 1.00 /share | 10.34% |
| 2026-02-03 | 2026-02-03 | Quarterly Result Announcement | NA | -2.77% |
| 2025-11-18 | 2025-11-18 | Dividend | ₹ 1.00 /share | 0.36% |
| 2025-11-10 | 2025-11-10 | Quarterly Result Announcement | NA | -1.32% |
| 2025-09-23 | 2025-09-23 | Annual General Meeting | NA | 15.67% |
| 2025-09-16 | 2025-09-16 | Dividend | ₹ 2.60 /share | 6.32% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -4.43% |
| 2025-05-15 | 2025-05-15 | Quarterly Result Announcement | NA | 5.45% |
| 2025-02-18 | 2025-02-18 | Dividend | ₹ 1.00 /share | -4.60% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -5.10% |
| 2024-11-22 | 2024-11-22 | Dividend | ₹ 1.00 /share | 0.77% |
Amrutanjan Health Care Competitors Screener - Peer Stocks Comparison
Screen AMRUTANJAN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 436,871 | 36.83 | 61,674 | 12.69% | 11,565 | 47.42 |
| Divis Laboratories | 248,041 | 86.00 | 11,067 | 13.95% | 2,568 | 58.71 |
| Torrent Pharmaceuticals | 184,554 | 86.72 | 13,886 | 20.34% | 2,138 | 48.14 |
| Zydus Life Science | 115,820 | 25.96 | 27,658 | 17.64% | 5,026 | 61.81 |
| Cipla | 110,006 | 33.29 | 29,045 | 2.24% | 3,870 | 44.03 |
| Laurus Labs | 106,609 | 98.39 | 6,868 | 22.01% | 890 | 58.00 |
| Dr Reddys Laboratories | 102,265 | 32.77 | 35,059 | 3.90% | 4,158 | 69.59 |
| Mankind Pharma | 101,436 | 50.84 | 14,636 | 14.85% | 1,938 | 64.24 |
| Aurobindo Pharma | 96,111 | 26.41 | 34,145 | 5.56% | 3,503 | 54.69 |
| Lupin | 92,921 | 16.97 | 29,039 | 26.75% | 5,356 | 34.02 |
Amrutanjan Health Care Company Announcements - News & Reports Screener
Screen AMRUTANJAN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 1, 2026.
The next most recent announcements are dated September 30, 2026 and September 29, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-01 | Closure of Trading Window | - |
| 2026-09-30 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-08-28 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-08-28 | Reg. 34 (1) Annual Report. | - |
| 2026-08-12 | Investor Presentation For The Quarter Ended 30Th June 2026 | - |
| 2026-08-11 | Record Date For The Final Dividend And AGM | - |
| 2026-08-11 | Board Meeting Outcome for Financial Results And Outcome Of The Board Meeting | - |
| 2026-08-06 | Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations 2015 | - |
| 2026-08-05 | Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results For The Quarter Ended 30Th June 2026 | - |
| 2026-08-05 | Commissioning Of New Manufacturing Facility | - |
| 2026-08-05 | Announcement under Regulation 30 (LODR)-Credit Rating | - |
| 2026-08-05 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-01 | Intimation Of Under Regulation 30 Read With Clause 20 Of Para A Of Part A Of Schedule Ill Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-07-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-24 | Closure of Trading Window | - |
| 2026-06-19 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | - |
| 2026-06-19 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-05-28 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-27 | Reconstitution Of Committees Of Board Of Directors. | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹518.10, within a 52-week range of ₹488.25 to ₹741.50. The P/B ratio is 3.95. Market capitalisation stands at ₹1,486.01 Cr and the dividend yield is 0.97%. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 5, 2026. This page covers 2 balance sheet periods, 3 income statement periods, 2 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.